Novo Nordisk A/S

Stock Chart, Company Information, and Scan Results

$55.62(as of Sep 15, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Novo Nordisk A/S Company Information, Fundamentals, and Technical Indicators

Stock Price$55.62
Ticker SymbolNVO
ExchangeNyse
SectorHealthcare
IndustryDrug Manufacturers - General
Employees78,387
CountyUSA
Market Cap$240,930.3M
EBIDTA159,261.0M
10-Day Moving Average55.22
P/E Ratio2.23
20-Day Moving Average55.41
Forward P/E Ratio13.09
50-Day Moving Average57.54
Earnings per Share3.91
200-Day Moving Average72.80
Profit Margin34.48%
RSI50.59
Shares Outstanding3,368.6M
ATR1.62
52-Week High131.57
Volume13,454,869
52-Week Low44.55
Most Recent Support Level53.55
Book Value168,066.0M
Most Recent Resistance Level55.24
P/B Ratio1.47
Upper Keltner59.05
P/S Ratio0.79
Lower Keltner51.77
Debt-to-Equity Ratio59.05
Next Earnings Date11/05/2025
Cash Surplus-189,087.0M
Next Ex-Dividend Date09/18/2025

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with UNICEF to tackle childhood obesity; and with Valo Health, Inc. to discover and develop novel drug programmes for cardiometabolic space. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Novo Nordisk A/S In Our Stock Scanner

As of Sep 16, 2025
As of ---
example chart graphic
Scan Name: Low PE RatiosScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: BreakoutsScan Type: Chart Pattern Scans
As of ---
As of ---
example chart graphic
Scan Name: Low PS RatioScan Type: Stock Fundamentals
As of ---
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.